Search Within

Parastoo Bahrami Dahi

  1. "Cardiology"
Formats
  1. Meeting Abstract (4)
  2. Journal Article (1)
Groups
  1. Bone Marrow Transplant (5)
  2. CTCR Scholars (5)
  3. Cardiology (5)
  4. Center for Hematologic Malignancies (5)
  5. Department of Medicine (5)
  6. Division of Subspecialty Medicine (5)

More Groups

People
  1. Maria Palomba (4)
  2. Craig Sauter (3)
  3. Sergio Giralt (3)
  4. Wendy Schaffer (3)
  5. Ahmed El-Moghraby (2)
  6. Ahmet Dogan (2)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2019 (1)
  4. 2017 (1)
  5. 2016 (1)
Publications
  1. Blood (3)
  2. Biology of Blood and Marrow Transplantation (1)
  3. British Journal of Haematology (1)
Publishers
  1. American Society of Hematology (3)
  2. Elsevier Inc. (1)
  3. John Wiley & Sons (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profile
    Journal Article

    Shouval, R.; Goldman, A.; Flynn, J. R.; El-Moghraby, A.; Rehman, M.; Devlin, S. M.; Corona, M.; Landego, I.; Lin, R. J.; Scordo, M.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • The impact of cardiovascular vulnerabilities in non Hodgkin lymphoma patients treated with chimeric antigen receptor T cell therapy
    Meeting Abstract

    Landego, I.; Flynn, J. R.; Goldman, A.; Devlin, S. M.; Luttwak, E.; Luna De Abia, A.; Corona, M.; Kedmi, M.; Sdayoor, I.; Fried, S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Late effects of autologous hematopoietic cell transplantation (AHCT) in elderly patients with lymphoma
    Meeting Abstract

    Dahi, P. B.; Obioha, C.; Kenny, S.; Hilden, P.; Maloy, M. A.; Geyer, A.; Schaffer, W. L.; Tamari, R.; Sauter, C. S.; Jakubowski, A. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • A phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory B-and T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M. A.; Lynch, P.; Scheuerman, M.; Minnal, V.; Galasso, N.; Kumar, A.; Gerecitano, J.; Zelenetz, A. D.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • A Phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M.; Lynch, P.; Scheuerman, M.; Kumar, A.; Gerecitano, J. F.; Zelenetz, A. D.; Hamlin, P. A. Jr; Noy, A.; more...
    Blood (2016)

    Fulltext@MSK | Save